Dabur India Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/ayv8eqj41qoyu6mrp223jvk8.pdf

Key Takeaways


The Inventory Reset: One-Off, Not Structural

Mohit Malhotra: "Whatever inventory correction we had to do, we quickly did it in 1 month only rather than prolonging this pain for a long time."

Urban & Rural Demand: Divergence Narrows

Mohit Malhotra: "So going forward, this gradual change from GT to MT to e-commerce is something which will endure. I don't think this is a flash in the pan and will disappear, and this change will come."

Category Performance: Broad-Based Share Gains

CategoryTrendCommentary
Hair Oils▲ GainingGrew ahead of category, gained 40 bps market share; coconut oils grew 14%; almond oil gained from the single largest player; Cool King launched and doing well.
Home Care▲ Strong9% YoY secondary sales; 220 bps share gain in air fresheners, 510 bps in mosquito repellent cream; portfolio on track from INR700 cr to INR1,000 cr in 2-3 years.
Oral Care▬ ResilientDabur Red secondary sales ~5%; strong number 2 position; number 1 in Orissa, Andhra Pradesh, Tamil Nadu; competitive intensity from market leader has risen but Dabur is matching on trade and visibility.
Chyawanprash▲ Strong12.6% secondary growth driven by monsoon campaign promoting all-weather consumption; 20 bps share gain to 61% market share; category penetration improved by 10 lakh households from pre-COVID.
Digestives▲ Good6% secondary growth led by Hajmola; 160 bps market share gain.
Foods▲ Strong20.6% secondary growth; Badshah grew 15% on 15% volume growth; business will cross INR500 cr this year.
Beverages▼ WeakJuices and Nectars category declined high single digits on aggressive monsoons, floods and landslides; Dabur gained 240 bps volume share despite slowdown. Nectars declined 12% as cola price war created collateral damage. 100% juices grew 7.3%, drinks portfolio at INR200 cr turnover.
Skin Care▼ SoftSecondaries down due to inventory correction collateral damage; real growth expected in winter given winter-skewed portfolio.
Health Care▲ Broad-basedHoney gained share; Baby Care ~30% growth; Shilajit high double-digit; Hajmola did well; Honitus declined on high base.
Mohit Malhotra: "I think it's a matter of time before the pricing will get normalized and this cola war should end, and we have been a little collateral damage in this cola war for past 6 months or so."

Sesa Acquisition: Filling the Ayurvedic Premium Gap

Mohit Malhotra: "The real rationale for acquisition is we are a INR2,000 crores business, and we want to solidify this business as it's a core business, we have market shares of 16%, and we have huge headroom for growth in terms of market share gain."

International Business: Oral Care Emerges as Second Vector


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue recoveryGrow back to mid-to-high single digits in H2, subject to good winters and FMCG performanceH2 FY25
Urban demandUrban FMCG growth to recover to around 3-3.5%Q3 FY25
Distributor inventory daysBring down from 21 days to 19-20 daysEnd-December 2024
Home Care scaleGrow portfolio from INR700 cr to ~INR1,000 cr2-3 years
Foods milestoneCross INR500 cr turnover this yearFY25
Sesa merger completionRegulatory approval and merger process1.5 to 2 years
Sesa operating marginPost-synergies margin to inch up to 18-19%Post full synergy realization
H2 marginsProtect margins at almost flattish levels via operating leverage as top line improvesH2 FY25
Namaste litigation resolutionBest estimate from lawyers~1.5 years, plus/minus 6 months
International marginsMargin improvement as currency depreciation laps overAs currencies lap

Key Metrics

MetricQ2 FY25
Consolidated revenueDeclined 5.5% YoY, impacted by one-time inventory rationalization initiative
Secondary sales growth2.3% YoY
Consolidated gross marginExpanded 102 bps YoY
Advertising and promotion spend7.4% of net sales, up from 6.8% in Q2 FY24
Operating profitDeclined 16.4% YoY, impacted by revenue deleverage
H1 operating margin correction~100 bps contraction at H1 level
Home and Personal Care secondary sales growth6% YoY
Health Care secondary sales growth4% YoY
International business constant currency growth13% YoY
Foods business secondary sales growth20.6% YoY
Badshah growth15% YoY, both primary and secondary, driven by 15% volume growth
Chyawanprash secondary growth12.6% YoY; market share reached 61%, up 20 bps
Juices and Nectar category volume declineHigh single digits YoY; Dabur gained 240 bps volume market share
Nectar business declineMinus 12% YoY
Distributor inventory days~21 days post-correction, down from 30 days; target ~19 days by December-end
Emerging channels salience~24% of overall business, growing at very high double digits
Namaste litigation spend₹40–45 cr in H1 FY25; full-year expected ₹85–90 cr, down from ₹110 cr in FY24